<!DOCTYPE html>
<html>
  <head>
    <title>2 new papers on absence epileptic rats | Serdar Akkol, MD PhD | Neurology Resident</title>
    <link rel="shortcut icon" type="image/jpg" href="/images/15dpi.png">
    <meta property="og:image" content="/images/residency-headshot.jpg">

        <meta charset="utf-8" />
    <meta content='text/html; charset=utf-8' http-equiv='Content-Type'>
    <meta http-equiv='X-UA-Compatible' content='IE=edge'>
    <meta name='viewport' content='width=device-width, initial-scale=1.0, maximum-scale=1.0'>

    
    <meta name="description" content="In a series of 2 papers I worked with one of my first mentors, Dr. Filiz Onat, and her team to elucidate the relationship between the alpha-2 receptor and the epileptogenesis on genetic absence epilepsy rats (GAERS).
" />
    <meta property="og:description" content="In a series of 2 papers I worked with one of my first mentors, Dr. Filiz Onat, and her team to elucidate the relationship between the alpha-2 receptor and the epileptogenesis on genetic absence epilepsy rats (GAERS).
" />
    
    <meta name="author" content="Serdar Akkol, MD PhD" />

    
    <meta property="og:title" content="2 new papers on absence epileptic rats" />
    <meta property="twitter:title" content="2 new papers on absence epileptic rats" />
    

    <!--[if lt IE 9]>
      <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script>
    <![endif]-->

    <link rel="stylesheet" type="text/css" href="/style.css" />
    <link rel="alternate" type="application/rss+xml" title="Serdar Akkol, MD PhD - Neurology Resident" href="/feed.xml" />
    <link rel="stylesheet" type="text/css" href="/icons/fontawesome.css">
    <link rel="stylesheet" type="text/css" href="/icons/academicons-1.9.1/css/academicons.css">
    <link rel="stylesheet" href="/icons/social-circles.min.css">
  </head>

  <body>
    <div class="wrapper-masthead">
      <div class="container">
        <header class="masthead clearfix">
          <a href="/" class="site-avatar"><img src="/images/residency-headshot.jpg" /></a>

          <div class="site-info">
            <h1 class="site-name"><a href="/">Serdar Akkol, MD PhD</a></h1>
            <p class="site-description">Neurology Resident</p>
          </div>

          <nav>
            <a href="/updates">Updates</a>
            <a href="/publications">Publications</a>
            <a href="/blog">Blog</a>
            <a href="https://drive.google.com/file/d/1VJs7BHmXxm25SYC5OJAAgjRs48_RBBIq/view?usp=sharing" target="_blank"  class="ai ai-cv ai-lg"></a>
        </header>
      </div>
    </div>


    <div id="main" role="main" class="container">
      <article class="post">
  <h1>2 new papers on absence epileptic rats</h1>

  <div class="entry">
    <p>In a series of 2 papers I worked with one of my first mentors, <a href="https://scholar.google.com.tr/citations?user=EdySxu4AAAAJ&amp;hl=en" target="_blank">Dr. Filiz Onat</a>, and her team to elucidate the relationship between the alpha-2 receptor and the epileptogenesis on genetic absence epilepsy rats (GAERS).</p>

<p>In the <a href="https://doi.org/10.3389/fneur.2023.1231736" target="_blank">first paper</a> published in Frontiers in Neurology, we studied the epileptogenesis in GAERS pups. We found that alpha-2 agonistic activity of dexmedetomidine induces an initial unilateral spike-wave discharges (SWD), a tell-tale finding of absence epilepsy. My contribution to this study was to analyze the EEG data to show that the unilateral 1.75Hz power activity during SWDs was stronger in left hemisphere than right.</p>

<p>In the <a href="https://doi.org/10.1002/epi4.12879" target="_blank">second paper</a> published in Epilepsia Open, we built on the idea of alpha-2 receptor agonism to initiate absence seizures. We showed that injection of dexmedetomidine triggered an absence status-like activity characterized by strong delta power and attenuated 7 Hz harmonics, which can be blocked by atipamezole.</p>

<p>Of course, both these studies were spearheaded by <a href="https://scholar.google.com.tr/citations?user=MqqA7g8AAAAJ&amp;hl=en" target="_blank">Dr. Melis Yavuz</a>, a champion of basic research on absence epilepsy, who gracefully included me in these projects.</p>

<p>Looking forward to advancing this line of projects! Hold tightâ€¦</p>

  </div>

  <div class="date">
    In December, 2023
  </div>

  
</article>

    </div>



    <div class="wrapper-footer">
      <div class="container">
        <footer class="footer">
          <div class="socialbtns">
    <ul>
	<a href="mailto:serdarakkol [a] gmail.com"><i class="fa fa-2x fa-envelope"></i></a>
        <li><a href="https://scholar.google.com.tr/citations?user=phI2qJwAAAAJ&hl=en" class="ai ai-google-scholar ai-2x"></a></li>
        <li><a href="https://www.twitter.com/sakkol_" class="fa fa-2x fa-twitter"></a></li>
        <li><a href="https://github.com/sakkol" class="fa fa-2x fa-github"></a></li>
        <li><a href="https://www.linkedin.com/in/serdar-akkol-mdphd" class="fa fa-2x fa-linkedin"></a></li>
        <li><a href="https://orcid.org/0000-0003-3643-169X" class="ai ai-orcid ai-2x"></a></li>
        <li><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Akkol+S&cauthor_id=33727335" class="ai ai-pubmed ai-2x"></a></li>
    </ul>
</div>

        </footer>
      </div>
    </div>

    

  </body>
</html>
